These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3872473)

  • 1. [Treatment of psoriatic rheumatism with a retinoid derivative: etretinate. Open preliminary trial on 12 patients reviewed after 6 months].
    Rampon S; Fraysse MP; Ristori JM; Sauvezie B; Bussière JL; Souteyrand P
    Rev Rhum Mal Osteoartic; 1985 Feb; 52(2):127-31. PubMed ID: 3872473
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined oral retinoid and PUVA therapy in the treatment of psoriasis and psoriatic arthropathy (author's transl)].
    Thivolet J; Robart S; Vignon E
    Ann Dermatol Venereol; 1981; 108(2):131-7. PubMed ID: 6972721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
    Frati C; Bevilacqua L; Apostolico V
    Acta Derm Venereol Suppl (Stockh); 1994; 186():151-3. PubMed ID: 8073820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of etretinate in psoriatic arthritis.
    Klinkhoff AV; Gertner E; Chalmers A; Gladman DD; Stewart WD; Schachter GD; Schachter RK
    J Rheumatol; 1989 Jun; 16(6):789-91. PubMed ID: 2778761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of psoriatic arthropathy with etretinate: a two-year follow-up.
    Chieregato GC; Leoni A
    Acta Derm Venereol; 1986; 66(4):321-4. PubMed ID: 2430403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Are retinoids active in the treatment of psoriatic rheumatism?].
    Bussière JL; Ristori JM
    Presse Med; 1988 Mar; 17(11):509-11. PubMed ID: 2965358
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experience with etretinate (Tigason) in 26 patients with psoriasis].
    Gajardo J
    Rev Med Chil; 1989 May; 117(5):516-22. PubMed ID: 2519162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of plaque psoriasis with an aromatic retinoid (etretinate)].
    Melis M
    Rev Med Chil; 1984 Jan; 112(1):20-5. PubMed ID: 6377426
    [No Abstract]   [Full Text] [Related]  

  • 9. [Unusual side effects in patients with psoriatic erythroderma treated with etretinate (RO 10-9359)].
    Castel T; Castro J; Lecha M; Mascaró JM
    Med Cutan Ibero Lat Am; 1986; 14(2):83-6. PubMed ID: 2943953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ro 10-9359, an aromatic retinoid in the treatment of psoriatic arthritis. Clinical and immunological studies.
    Rosenthal M
    Arzneimittelforschung; 1982; 32(8):842-4. PubMed ID: 6890362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of RePUVA and aromatic retinoid Ro 10-9359 with methotrexate in severe forms of psoriasis].
    Mashkilleysson AL; Mashkilleysson NA
    Hautarzt; 1983 May; 34(5):229-30. PubMed ID: 6862887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etretinate therapy in generalized pustular psoriasis (Zumbusch type). Immediate and long-term results.
    Wolska H; Jabłonska S; Langner A; Fraczykowska M
    Dermatologica; 1985; 171(5):297-304. PubMed ID: 3908171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of psoriasis with etretinate (Tigason)].
    Schuppli R
    Ther Umsch; 1986 Sep; 43(9):684-8. PubMed ID: 3535152
    [No Abstract]   [Full Text] [Related]  

  • 14. [Psoriasis therapy with the aromatic retinoid Ro 10-9359 (Tigason)].
    Sönnichsen N; Harnack K; Barth J; Heilmann S; Jäger K; Metz D; Schiller F
    Z Hautkr; 1983 Sep; 58(17):1257-67. PubMed ID: 6636927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retinoid treatment of pediatric skin diseases].
    Kuokkanen K
    Duodecim; 1989; 105(8):772-7. PubMed ID: 2721405
    [No Abstract]   [Full Text] [Related]  

  • 16. Methotrexate and etretinate as concurrent therapies in severe psoriasis.
    Vanderveen EE; Ellis CN; Campbell JP; Case PC; Voorhees JJ
    Arch Dermatol; 1982 Sep; 118(9):660-2. PubMed ID: 7114868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of etretinate (RO-10-9359) in intermittent doses and follow-up for 1 year in patients with psoriasis. Final report].
    Domínguez Soto L; Hokyo Tomoka MT; Armas JJ
    Med Cutan Ibero Lat Am; 1984; 12(1):47-56. PubMed ID: 6376979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Razoxane in the treatment of psoriatic patients resistant to or intolerant of PUVA, methotrexate and etretinate.
    Mom A; Aresca S; Fuente G; Pecorini V; Pellerano G; Perez V
    Acta Derm Venereol; 1982; 62(4):357-8. PubMed ID: 6183878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dermatoses difficult to treat. Their treatment with an aromatic retinoid (etretinate)].
    Solano E; Hidalgo H
    Med Cutan Ibero Lat Am; 1983; 11(5):369-71. PubMed ID: 6230492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etretinate therapy causes increases in lipid levels in patients with psoriasis.
    Ellis CN; Swanson NA; Grekin RC; Goldstein NG; Bassett DR; Anderson TF; Voorhees JJ
    Arch Dermatol; 1982 Aug; 118(8):559-62. PubMed ID: 7103524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.